Clinical Trials · NCT07481734
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Hudson Biotech
- Enrollment
- 120
- Start date
- Feb 2026
- Locations
- 1 site, China
- Primary endpoint
- Change from baseline in hepatic fat fraction by MRI-PDFF (percentage points)